NCT04403438

Brief Summary

Behcet' disease (BD) is a chronic inflammatory disease which is characterized by oral and genital ulcers, uveitis and skin lesions. Musculoskeletal involvement such as arthrits, arthralgia, enthesis and sacroiliitis can be seen in course of BD. FMF is an autosomal recessive family disease characterized by abdominal pain, chest pain, joint pain and fever attacks as a result of inflammation of the serous membranes. FMF patients have been shown to experience higher levels of pain, fatigue, depression and anxiety than healthy controls, and this has increased sleep disturbance and reduced quality of life. FMF and BiH have common characteristics such as ethnicity, etiopathogenetic mechanisms, symptoms, and treatment. In December 2019, after the officially detected coronavirus (severe acute respiratory syndrome coranavirus-2 \[SARS-CoV-2\]) resistant to unknown treatment and rapidly spreading coronavirus in our country on March 11, 2020 in Hubei province of China, the number of cases increased rapidly and virus was isolated in 670 patients within 10 days. Ongoing concerns about the spread of Covid-19 infections have caused many measures to be taken. Among them, social isolation, home quarantine and avoiding collective places are the most important. In our country, in the process of social isolation, the areas of movement of Behçet and FMF patients, like everyone else, were restricted, their stress and anxiety levels increased and their motivation decreased. The aim of our study is to compare the pain, sleep, fatigue, physical activity level and quality of life and question exercise habits before and after the covid-19 outbreak in patients with Behçet and FMF.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
45

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Apr 2020

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 1, 2020

Completed
1 month until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2020

Completed
22 days until next milestone

First Submitted

Initial submission to the registry

May 23, 2020

Completed
4 days until next milestone

First Posted

Study publicly available on registry

May 27, 2020

Completed
10 months until next milestone

Study Completion

Last participant's last visit for all outcomes

March 15, 2021

Completed
Last Updated

February 4, 2025

Status Verified

June 1, 2023

Enrollment Period

1 month

First QC Date

May 23, 2020

Last Update Submit

February 2, 2025

Conditions

Outcome Measures

Primary Outcomes (2)

  • IPAQ-SF

    The Turkish validity and reliability study of this short questionnaire consisting of seven questions, which evaluates in detail the amount of walking performed in the last week and the amount of moderate and difficult physical activity performed in work, transportation, housework, gardening and leisure activities.

    one assesment baseline

  • Numeric Rating Scale

    It has horizontal and vertical forms. In this scale, the starting point is the point where there is no pain, and the ending point is the end point where the pain is worst

    one assesment baseline

Secondary Outcomes (4)

  • Short-Form 36 Health Survey (SF-36)

    one assesment baseline

  • Exercise Stage of Change Questionnaire

    one assesment baseline

  • Exercise Self-Efficacy Questionnaire

    one assesment baseline

  • Decisional Balance Questionnaire

    one assesment baseline

Study Arms (1)

patients with behçet's or fmf

Other: ıt will be compared pain, sleep, fatigue, physical activity level and quality of life and questioning exercise habits before and after the covid-19 outbreak in patients with Behçet and FMF.

Interventions

ıt will be compared pain, sleep, fatigue, physical activity level and quality of life and questioning exercise habits before and after the covid-19 outbreak in patients with Behçet and FMF.

patients with behçet's or fmf

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

In patients with Behçet and FMF between the ages of 18-65, exercise habits will be questioned by comparing pain, sleep, fatigue, physical activity level and quality of life before and after the covid-19 outbreak.

You may qualify if:

  • Being between the ages of 18-65
  • Being diagnosed with FMF at least 1 year ago according to diagnostic criteria
  • A diagnosis of BiH at least 1 year ago according to the International Behçet Working Group
  • Having signed the informed consent form
  • Having a cooperative level that will respond to evaluation scales

You may not qualify if:

  • Pregnant women
  • Having other chronic diseases
  • Psychiatric disorders and treated
  • Those with cognitive impairment

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

IstanbulU

Istanbul, Bakırköy, 34740, Turkey (Türkiye)

Location

MeSH Terms

Conditions

Behcet Syndrome

Interventions

SleepQuality of LifePyrin

Condition Hierarchy (Ancestors)

Mouth DiseasesStomatognathic DiseasesUveitis, AnteriorPanuveitisUveitisUveal DiseasesEye DiseasesVasculitisVascular DiseasesCardiovascular DiseasesHereditary Autoinflammatory DiseasesGenetic Diseases, InbornCongenital, Hereditary, and Neonatal Diseases and AbnormalitiesSkin Diseases, GeneticSkin DiseasesSkin and Connective Tissue DiseasesSkin Diseases, Vascular

Intervention Hierarchy (Ancestors)

Nervous System Physiological PhenomenaMusculoskeletal and Neural Physiological PhenomenaHealth StatusDemographyEpidemiologic MeasurementsPublic HealthEnvironment and Public HealthCytoskeletal ProteinsProteinsAmino Acids, Peptides, and ProteinsTripartite Motif Proteins

Study Officials

  • nejla uzun, MSc, Pt

    Istanbul University - Cerrahpasa

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
MSc, Pt

Study Record Dates

First Submitted

May 23, 2020

First Posted

May 27, 2020

Study Start

April 1, 2020

Primary Completion

May 1, 2020

Study Completion

March 15, 2021

Last Updated

February 4, 2025

Record last verified: 2023-06

Data Sharing

IPD Sharing
Will not share

Locations